Nilofer Azad, MD, FASCO, on COMPANION-002: paclitaxel ± tovecimig (anti-VEGF/DLL4 bispecific) in previously treated advanced biliary tract cancer. #ESMO26

返回会议原文

返回会议

OncologyEducation· @OncEd · X·2026-10-25 06:54· 6 小时前评分45

paclitaxel

正文 · 机器翻译

Nilofer Azad, MD, FASCO，介绍 COMPANION-002：paclitaxel ± tovecimig（抗VEGF/DLL4双特异性）用于既往经治的晚期胆道癌。#ESMO26

立即观看：https://bit.ly/4BqfVO2

14 浏览 · 0 赞 · 0 转发 · 0 回复

会议摘要

2878RO按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for taxane-pretreated patients with advanced or metastatic gastroesophageal adenocarcinoma–Final results of the phase III IKFs602/AIO RAMIRIS Study

https://esmocongress.esmo.org

543RO按 Rapid oral: Breast cancer, early stage 对上

DESTINY-Breast11: MRI-assessed objective responses during neoadjuvant treatment (NAT) with trastuzumab deruxtecan (T-DXd) followed by paclitaxel + trastuzumab + pertuzumab (THP) vs dose-dense doxorubicin + cyclophosphamide followed by THP (

https://esmocongress.esmo.org

LBA37按 Proffered paper: Gynaecological cancers 对上

Durvalumab (D) plus carboplatin/paclitaxel (CP) followed by D with or without olaparib (O) in advanced/recurrent endometrial cancer (a/rEC): Interim overall survival (OS) and safety from the randomised phase 3 DUO-E/GOG-3041/ENGOT-EN10 stud

https://esmocongress.esmo.org

来源：OncologyEducation · x.com